Molecular modeling elucidates the cellular mechanism of synaptotagmin-SNARE inhibition: a novel plausible route to anti-wrinkle activity of botox-like cosmetic active molecules
Modelagem molecular elucida o mecanismo celular da inibição sinaptotaginina-SNARE: nova rota plausível para atividade antirrugas de moléculas cosméticas tipo botox
Bhogale D, Bhagwat P, Bhojwani H
Mol Cell Biochem
Summary
This study used advanced molecular modeling and computational simulation techniques to elucidate the mechanism of action of anti-wrinkle cosmetic peptides, focusing on SNAP-8 (acetyl octapeptide-3). The researchers investigated how these peptides interact with components of the SNARE complex, responsible for synaptic vesicle fusion and neurotransmitter release at the neuromuscular junction.
The modeling results demonstrated that SNAP-8 specifically interacts with synaptotagmin-1 (Syt-1), a calcium-sensing protein essential for synaptic vesicle exocytosis. By binding to Syt-1, the peptide blocks the neurotransmitter release cascade, reducing the facial muscle contraction responsible for expression wrinkle formation.
- The model revealed specific binding sites between SNAP-8 and synaptotagmin-1
- The proposed mechanism differs from botulinum toxin, which directly cleaves SNARE proteins
- The SNAP-8 approach is more subtle, modulating the pathway rather than completely blocking it
- The simulations were validated with experimental data from previous studies
This work contributed significantly to the scientific understanding of peptide cosmeceuticals by providing a plausible mechanistic explanation for the anti-wrinkle activity of SNAP-8, distinguishing it from other peptides that act through direct cleavage of the SNARE complex (such as argireline/SNAP-25).
Related Peptide
SNAP-8
Acetyl Octapeptide-3, INYIM
Acetylated octapeptide with anti-wrinkle action. Modulates the SNARE complex to reduce facial muscle contraction, diminishing expression lines. Enhanced version of Argireline with two additional amino acids for greater efficacy.